His latest experience as R&D Program Director of the Air Liquide Group will help him lead the company’s research and innovation programme
Hannes Moeller has been appointed MD of Seppic, effective April 1, 2022.
A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes a range of specialty ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products. The company boasts multiple areas of expertise including polymers, surfactants and emulsion technologies, active ingredients, biology, immunology, formulation, green chemistry, extraction and biotechnologies.
Moeller has acquired international experience and held management positions within the Air Liquide Group since 2008, as Distribution Director, then Industrial Merchant Director Food & Pharma for Central-West Europe.
His latest experience as R&D Program Director of the Air Liquide Group will help him lead the company’s research and innovation programme, which aims to support profitable and sustainable growth, based on responsible innovation. Seppic places these priorities at the heart of its vision and corporate strategy.